A detailed history of Axq Capital, LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Axq Capital, LP holds 25,794 shares of BSX stock, worth $2.16 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
25,794
Previous 18,100 42.51%
Holding current value
$2.16 Million
Previous $1.24 Billion 60.24%
% of portfolio
0.46%
Previous 0.3%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $518,037 - $597,900
7,694 Added 42.51%
25,794 $1.99 Billion
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $1.04 Million - $1.24 Million
18,100 New
18,100 $1.24 Billion
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $798,522 - $869,958
15,910 Added 183.08%
24,600 $1.3 Billion
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $432,066 - $474,821
8,690 New
8,690 $470 Million
Q4 2022

Feb 10, 2023

BUY
$39.56 - $47.22 $276,920 - $330,540
7,000 New
7,000 $324 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.